EssilorLuxottica Société anonyme Future Growth
Future criteria checks 1/6
EssilorLuxottica Société anonyme se prevé un crecimiento anual de los beneficios y los ingresos de 14.3% y 5.2% respectivamente. Se prevé que el BPA sea de grow en 14.4% al año. Se prevé que la rentabilidad de los fondos propios sea de 9.5% en 3 años.
Key information
13.9%
Earnings growth rate
12.6%
EPS growth rate
Medical Equipment earnings growth | 18.2% |
Revenue growth rate | 5.2% |
Future return on equity | 9.5% |
Analyst coverage | Good |
Last updated | 09 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 29,922 | 3,664 | 4,443 | 6,693 | 16 |
12/31/2025 | 28,317 | 3,294 | 3,783 | 6,215 | 19 |
12/31/2024 | 26,748 | 2,933 | 3,393 | 5,814 | 20 |
12/31/2023 | 25,395 | 2,289 | 3,330 | 4,861 | N/A |
9/30/2023 | 25,373 | 2,314 | 3,295 | 4,838 | N/A |
6/30/2023 | 25,351 | 2,339 | 3,260 | 4,815 | N/A |
3/31/2023 | 24,923 | 2,246 | 3,236 | 4,799 | N/A |
12/31/2022 | 24,494 | 2,152 | 3,211 | 4,783 | N/A |
9/30/2022 | 23,770 | 1,960 | 3,308 | 4,784 | N/A |
6/30/2022 | 23,046 | 1,768 | 3,404 | 4,784 | N/A |
3/31/2022 | 21,433 | 1,608 | 3,460 | 4,665 | N/A |
12/31/2021 | 19,820 | 1,448 | 3,515 | 4,545 | N/A |
9/30/2021 | 18,394 | 1,400 | 3,582 | 4,475 | N/A |
6/30/2021 | 16,967 | 1,351 | 3,648 | 4,404 | N/A |
3/31/2021 | 15,698 | 718 | 2,976 | 3,679 | N/A |
12/31/2020 | 14,429 | 85 | 2,303 | 2,953 | N/A |
9/30/2020 | 14,637 | 40 | 1,895 | 2,609 | N/A |
6/30/2020 | 14,844 | -6 | 1,487 | 2,264 | N/A |
3/31/2020 | 16,117 | 536 | 1,942 | 2,782 | N/A |
12/31/2019 | 17,390 | 1,077 | 2,396 | 3,299 | N/A |
9/30/2019 | 16,215 | 1,151 | 2,276 | 3,152 | N/A |
6/30/2019 | 15,040 | 1,224 | 2,156 | 3,004 | N/A |
3/31/2019 | 12,937 | 1,154 | 1,903 | 2,682 | N/A |
12/31/2018 | 10,833 | 1,083 | 1,649 | 2,359 | N/A |
9/30/2018 | 10,364 | 1,132 | 1,401 | 2,175 | N/A |
6/30/2018 | 9,894 | 1,181 | 1,152 | 1,991 | N/A |
3/31/2018 | 9,539 | 1,111 | 1,046 | 1,797 | N/A |
12/31/2017 | 9,184 | 1,040 | 939 | 1,603 | N/A |
9/30/2017 | 8,288 | 913 | N/A | 1,431 | N/A |
6/30/2017 | 7,391 | 786 | N/A | 1,258 | N/A |
3/31/2017 | 7,253 | 800 | N/A | 1,226 | N/A |
12/31/2016 | 7,115 | 813 | N/A | 1,194 | N/A |
9/30/2016 | 7,003 | 799 | N/A | 1,188 | N/A |
6/30/2016 | 6,891 | 785 | N/A | 1,182 | N/A |
3/31/2016 | 6,804 | 771 | N/A | 1,188 | N/A |
12/31/2015 | 6,716 | 757 | N/A | 1,194 | N/A |
9/30/2015 | 6,507 | 688 | N/A | 1,140 | N/A |
6/30/2015 | 6,298 | 618 | N/A | 1,085 | N/A |
3/31/2015 | 5,984 | 774 | N/A | 1,059 | N/A |
12/31/2014 | 5,670 | 929 | N/A | 1,032 | N/A |
9/30/2014 | 5,470 | 956 | N/A | 941 | N/A |
6/30/2014 | 5,269 | 982 | N/A | 850 | N/A |
3/31/2014 | 5,167 | 788 | N/A | 847 | N/A |
12/31/2013 | 5,065 | 593 | N/A | 843 | N/A |
9/30/2013 | 5,050 | 593 | N/A | 869 | N/A |
6/30/2013 | 5,035 | 593 | N/A | 895 | N/A |
Analyst Future Growth Forecasts
Ingresos vs. tasa de ahorro: ESL(14.3% al año) es superior a la tasa de ahorro (0.6%).
Beneficios frente mercado: ESLSe prevé que los beneficios de la empresa (14.2% al año) crezcan menos que el mercado German (14.5% al año).
Beneficios de alto crecimiento: ESLSe prevé que los beneficios de la empresa crezcan, pero no significativamente.
Ingresos vs. Mercado: ESL(5.4% al año) se prevé que crezca más despacio que el mercado de German (5.4% al año).
Ingresos de alto crecimiento: ESLSe prevé que los ingresos de la empresa (5.2% al año) crezcan más despacio que 20% al año.
Earnings per Share Growth Forecasts
Future Return on Equity
Futura rentabilidad financiera (ROE): ESLSe prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (9.5%).